<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Chemoradiotherapy-induced toxicity following unmodified allogeneic marrow grafting was studied </plain></SENT>
<SENT sid="1" pm="."><plain>Patients with <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematologic malignancy</z:e> (n = 157) received <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> (120 mg/kg) followed by single or fractionated total body irradiation (TBI); <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> patients (n = 41) received only <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> (200 mg/kg) </plain></SENT>
<SENT sid="2" pm="."><plain>Physicians rated mucositis, pain and <z:hpo ids='HP_0002018'>nausea</z:hpo> daily as (0) none, (1) mild, (2) moderate, (3) severe, (4) life threatening </plain></SENT>
<SENT sid="3" pm="."><plain><z:e sem="disease" ids="C1568868" disease_type="Disease or Syndrome" abbrv="">Oral mucositis</z:e> pain began several days prior to transplant, peaked during the second week after transplant, and declined thereafter </plain></SENT>
<SENT sid="4" pm="."><plain>Patients with <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematologic malignancies</z:e> (maximum mean rating of 1.6, day 11) experienced more pain than <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> patients (maximum mean rating of 0.7, day 6) </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0002018'>Nausea</z:hpo> peaked before transplant and gradually declined </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0002018'>Nausea</z:hpo> was higher (p less than 0.001) in patients with <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> (maximum mean rating of 1.3, day -2) than with <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematologic malignancies</z:e> (maximum mean rating of 0.9, day -6) </plain></SENT>
<SENT sid="7" pm="."><plain>There was no significant difference between single dose 1000 cGy and 6-day 1200 cGy irradiation </plain></SENT>
<SENT sid="8" pm="."><plain>Recipients of 1575 cGy rather than 1200 cGy TBI had significantly (p less than 0.01) higher levels of pain (mean rating 1.25 and 0.82, respectively) and <z:hpo ids='HP_0002018'>nausea</z:hpo> (mean rating 1.27 and 0.72, respectively) </plain></SENT>
<SENT sid="9" pm="."><plain>Additional research is needed to determine the predictors, consequences and best methods of controlling these toxicities </plain></SENT>
</text></document>